Single Ascending Dose Study With Healthy Male Volunteers and Type II Diabetic Patients The purpose of this study is to assess safety and tolerability of AZD6714 after single ascending oral doses in healthy male subjects and type 2 diabetic patients.

• Country Sweden
• organs None
• Specialty None

Study to Assess the Effect of Ticagrelor on Coronary Blood Flow in Healthy Male Subjects The purpose of this study is to determine if Ticagrelor increases the Adenosin induced coronary blood flow velocity.

• Country None
• organs None
• Specialty None

Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017 The primary aim of this study is to investigate the safety and tolerabilty of AZD4017 when given as single oral ascending doses to healthy volunters. This will be done by comparing the eff...

• Country None
• organs None
• Specialty None

Study to Investigate Safety, Tolerability and Pharmacokinetics With Single and Multiple Ascending Doses of AZD1446 This study is designed to evaluate the safety, tolerability and PK of AZD1446 in Subjects when given as multiple dose administration for either 7 Days (Day 1 single dose, Day 2-6 multiple ...

• Country Sweden
• organs None
• Specialty None

AZD5985 Single Ascending Dose Study The aims of this study are to assess the safety, tolerability and pharmacokinetics of single ascending oral doses of AZD5985 in healthy male subjects.

• Country Sweden
• organs None
• Specialty None

Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4017 After Repeated Ascending Oral Doses The primary aim of this study is to investigate the safety and tolerability of AZD4017 when given as multiple oral ascending doses to healthy volunteers. This will be done by comparing the...

• Country None
• organs None
• Specialty None

Single Ascending Dose Study (SAD) iv Formulation The purpose is to study the safety of AZD1305, how AZD1305 is tolerated and how the medication is metabolised by the body (how it is taken up into the body, distributed around the body and...

• Country Sweden
• organs None
• Specialty None

Study of an Extended Release (ER) Tablet, Single and Repeated Dosing The purpose is to study the safety and tolerability of increasing doses of AZD1305 and how the medication is metabolised by the body (how it is taken up, distributed, and how it disappears...

• Country None
• organs None
• Specialty None

Investigate the Effect of AZD1305 on Patients With Left Ventricular Dysfunction To explore if AZD1305 compromises left ventricular performance in patients with left ventricular dysfunction

• Country None
• organs None
• Specialty None

Study to Investigate Safety and Tolerability of a Single Dose of AZD6482 AZD6482 is a new drug substance aiming to prevent blood clots which may arise in atherosclerotic blood vessels and cause myocardial infarction or stroke. This is the first study with AZD64...

• Country None
• organs None
• Specialty None